Evoke Wealth’s Hims & Hers Health HIMS Stock Holding History

Evoke Wealth’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-13,754	Closed	-$136K	–	374
2023 Q1	$136K	Hold	13,754	–	–	0.01%	338
2022 Q4	$88.2K	Hold	13,754	–	–	﹤0.01%	349
2022 Q3	$77K	Hold	13,754	–	–	﹤0.01%	452
2022 Q2	$62K	Buy	+13,754	New	+$58.7K	﹤0.01%	482

Other funds holding HIMS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return

IVMX

Institutional Venture Management XVI Menlo Park, California $1.18M AUM 156.01% 1-Year Est. Return

IVMX

Institutional Venture Management XV Menlo Park, California $75.5M AUM 16.43% 1-Year Est. Return

Redpoint Management Woodside, California $201M AUM 39.14% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

NCPI

NewView Capital Partners I Burlingame, California $28M AUM 10.55% 1-Year Est. Return

Evoke Wealth's HIMS Position: Q2 2023 in Review

Evoke Wealth sold out of Hims & Hers Health (HIMS) in Q2 2023, closing a stake of 13,754 shares — an estimated $136K sold.

Evoke Wealth first reported a position in HIMS in Q2 2022 and held it in 4 quarters. The position peaked at $136K in Q1 2023. 190 funds tracked by Wall St. Rank hold HIMS as of Q2 2023.

Evoke Wealth reported no remaining Hims & Hers Health position as of Q2 2023 after selling out during the quarter.
Evoke Wealth sold 13,754 Hims & Hers Health shares in Q2 2023, an estimated $136K.
Evoke Wealth first reported a position in Hims & Hers Health in Q2 2022 and held it in 4 quarters.
Evoke Wealth's Hims & Hers Health position peaked at $136K in Q1 2023.
190 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2023.

Based on Evoke Wealth's 13F filing for Q2 2023, filed 9 Aug 2023.